|
ITGB1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.40269998236431E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.51819998187131E-09 |
| Normal-vs-Stage2 |
2.003800E-01 |
| Normal-vs-Stage3 |
2.952800E-04 |
| Normal-vs-Stage4 |
7.447600E-04 |
| Stage1-vs-Stage2 |
1.068460E-02 |
| Stage1-vs-Stage3 |
6.024600E-01 |
| Stage1-vs-Stage4 |
7.813000E-01 |
| Stage2-vs-Stage3 |
5.969700E-02 |
| Stage2-vs-Stage4 |
3.422300E-02 |
| Stage3-vs-Stage4 |
5.782800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.47959999807767E-08 |
| Normal-vs-AfricanAmerican |
9.236700E-04 |
| Normal-vs-Asian |
7.52280000000383E-05 |
| Caucasian-vs-AfricanAmerican |
1.524770E-01 |
| Caucasian-vs-Asian |
3.872600E-01 |
| AfricanAmerican-vs-Asian |
4.969200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.80550000000923E-06 |
| Normal-vs-Female |
2.19950000435176E-08 |
| Male-vs-Female |
8.221000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.1626000162579E-09 |
| Normal-vs-Age(41-60Yrs) |
3.75019999999671E-05 |
| Normal-vs-Age(61-80Yrs) |
4.422300E-03 |
| Normal-vs-Age(81-100Yrs) |
2.840600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.245860E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.594200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.712400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.996600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.452200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.832800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.947200E-01 |
| Classical-VS-Follicular |
7.97080179637533E-11 |
| Classical-VS-Other |
4.501000E-01 |
| Classical-VS-Normal |
1.25309762566417E-11 |
| Tall-VS-Follicular |
1.617730E-03 |
| Tall-VS-Other |
3.555200E-01 |
| Tall-VS-Normal |
1.183440E-03 |
| Follicular-VS-Other |
1.949970E-01 |
| Follicular-VS-Normal |
8.200600E-01 |
| Other-VS-Normal |
3.470400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.324700E-03 |
| Normal-vs-N1 |
2.609700E-04 |
| N0-vs-N1 |
3.217700E-02 |
|
|
